Clarivate Stock Has Tanked 42%, and One Fund Just Ditched a $43 Million Stake

Core Insights - HG Vora Capital Management sold all 11,125,000 shares of Clarivate, resulting in a net position change of $42.61 million [2][6] Company Overview - Clarivate's stock price is $2.45, with a market capitalization of $1.6 billion and a revenue of $2.50 billion [4] - The company reported a net income of -$396 million [4] - Clarivate provides structured information and analytics, supporting research, intellectual property, and brand management through a subscription-driven model [5][8] Financial Performance - In 2025, Clarivate generated $2.46 billion in revenue, a decrease from $2.56 billion in 2024, with free cash flow of $365.3 million [10] - Organic annualized contract value increased by 1.8%, and recurring revenue now constitutes 88% of total sales, indicating improved revenue quality [10] Market Position and Strategy - Clarivate's shares have decreased by 42% over the past year, underperforming the S&P 500, which rose by about 16% in the same period [7] - The company is undergoing a strategic reset, with plans to explore the sale of its Life Sciences segment to reduce its total debt of $4.47 billion [10] - Clarivate is viewed as a restructuring story, with potential for attractive pricing if recurring revenue growth and deleveraging accelerate [11]